uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Over the BBB and into the cell: Pursuing intracellular targets for immunotherapy of Parkinson’s disease
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Pharmaceutical Biosciences. (Protein Drug Design)
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Pharmaceutical Biosciences.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences, Geriatrics.
Show others and affiliations
2019 (English)Conference paper, Poster (with or without abstract) (Refereed)
Abstract [en]

The aim of our research is to modify therapeutic antibodies so that they can reach their dementia target inside cells located on the other side of the blood brain barrier. While the aggregates associated with Alzheimer’s are located extracellularly and thus readily available for antibodies that have crossed the BBB barrier, this is not the case for Parkinson’s disease. In this study, we focus on developing a peptide shuttle that can deliver antibodies not only over the BBB but also into neuronal cells where the Tau and a-synuclein aggregates can be found.

For this purpose, we have investigated the use of a peptide which binds to a receptor that co- localizes with the aggregates. Our in-house experience suggests that the peptide is not an efficient BBB transporter despite the fact that some groups have used it as such, but that it might be more suitable as a transporter for intracellular delivery.

We have successfully expressed recombinant antibodies with the peptide on the N-terminal of an antibody targeting the aggregates associated with Parkinson’s disease. Our initial studies indicate that the tyrosine on the N-terminal of the peptide needs to be free and unmodified to be able to enhance uptake into neuronal cells. This hinders the use of the normal labelling method which attaches radiolabelled iodine to tyrosines where the affinity for peptide target would be destroyed. We have been pursuing alternative methods, such as using click chemistry to attach the peptide which will leave the antibody free to be radiolabelled, as well as methods to detect unlabelled antibodies in vivo and in vitro.

We have assessed the peptide-assisted increase in uptake in appropriate neuronal cell line models. Furthermore, we have studied uptake and retention in brain in mouse models for Parkinson’s disease.

Place, publisher, year, edition, pages
2019.
Keywords [en]
Protein drug design, blood-brain-barrier, neurodegenerative diseases, immunotherapy, antibody-based drugs
National Category
Pharmaceutical Sciences
Identifiers
URN: urn:nbn:se:uu:diva-401539OAI: oai:DiVA.org:uu-401539DiVA, id: diva2:1383571
Conference
15th annual PEGS: The Essential Protein Engineering & Cell Therapy Summit, Boston April 8-12 2019
Available from: 2020-01-08 Created: 2020-01-08 Last updated: 2020-01-08

Open Access in DiVA

No full text in DiVA

Authority records BETA

Roshanbin, SaharAguilar, XimenaErlandsson, AnnaSehlin, DagSyvänen, StinaHultqvist, Greta

Search in DiVA

By author/editor
Stenler, SofiaRoshanbin, SaharAguilar, XimenaErlandsson, AnnaSehlin, DagSyvänen, StinaHultqvist, Greta
By organisation
Department of Pharmaceutical BiosciencesGeriatricsDepartment of NeuroscienceDepartment of Medical Biochemistry and MicrobiologyDepartment of Cell and Molecular Biology
Pharmaceutical Sciences

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 14 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf